Mutations of follicle-stimulating hormone and its receptor: effects on gonadal function.

The physiological functions of the two gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), are quite well known in both males and females. Nevertheless, the recent unraveling of structures of the gonadotropin and gonadotropin receptor genes has provided us with tools to obtain completely new information on the functions of these hormones at the molecular level. Several gain- and loss-of-function mutations of these genes have been discovered in humans, and the first knock-out experiments with these genes in the mouse have been recently published. The purpose of the present review is to describe the current state of knowledge on human mutations of FSH and its receptor, as well as on relevant animal models.

[1]  H. Burger,et al.  No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. , 1998, The Journal of clinical endocrinology and metabolism.

[2]  E. Nieschlag,et al.  The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. , 1997, Endocrine reviews.

[3]  E. J. Lee,et al.  Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene , 1997 .

[4]  V. Chatterjee,et al.  Isolated deficiency of follicle-stimulating hormone re-revisited. , 1997, The New England journal of medicine.

[5]  J. Martens,et al.  Gonadotropin receptor mutations. , 1997, The Journal of endocrinology.

[6]  I. Thompson.  Reproductive Endocrinology, Surgery and Technology , 1997 .

[7]  R. Scully,et al.  A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. , 1997, The Journal of clinical endocrinology and metabolism.

[8]  K. Aittomäki,et al.  Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility , 1997, Nature Genetics.

[9]  M. Matzuk,et al.  Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility , 1997, Nature Genetics.

[10]  E. Nieschlag,et al.  Functional and clinical consequences of mutations in the FSH receptor , 1996, Molecular and Cellular Endocrinology.

[11]  A. de la Chapelle,et al.  Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. , 1996, The Journal of clinical endocrinology and metabolism.

[12]  E. Nieschlag,et al.  The structure and organization of the human follicle-stimulating hormone receptor (FSHR) gene. , 1996, Genomics.

[13]  A. Spiegel,et al.  Mutations in G proteins and G protein-coupled receptors in endocrine disease. , 1996, The Journal of clinical endocrinology and metabolism.

[14]  E. Nieschlag,et al.  An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. , 1996, The Journal of clinical endocrinology and metabolism.

[15]  C. O'neill,et al.  Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. , 1995, Endocrinology.

[16]  V. Padmanabhan,et al.  Follicle-stimulating isohormones: characterization and physiological relevance. , 1995, Endocrine reviews.

[17]  A. Chapelle,et al.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure , 1995, Cell.

[18]  P. McDonough,et al.  The follicle-stimulating hormone receptor gene is polymorphic in premature ovarian failure and normal controls. , 1995, Fertility and sterility.

[19]  S. Swillens,et al.  Somatic and germline mutations of the TSH receptor gene in thyroid diseases. , 1995, The Journal of clinical endocrinology and metabolism.

[20]  R. Wood,et al.  Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice. , 1995, Genes & development.

[21]  M. Griswold,et al.  Is FSH required for adult spermatogenesis? , 1994, Journal of andrology.

[22]  K. Aittomäki.  The genetics of XX gonadal dysgenesis. , 1994, American journal of human genetics.

[23]  P. Iglesias,et al.  Isolated deficiency of follicle-stimulating hormone in man: a case report and literature review. , 1994, International journal of fertility and menopausal studies.

[24]  P. Beck‐Peccoz,et al.  Primary amenorrhoea and infertility due to a mutation in the β–subunit of follicle–stimulating hormone , 1993, Nature Genetics.

[25]  R. Berger,et al.  The chromosomal localization of the human follicle-stimulating hormone receptor gene (FSHR) on 2p21-p16 is similar to that of the luteinizing hormone receptor gene. , 1993, Genomics.

[26]  S. Overton,et al.  The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO, and Y-1 cells , 1992, Molecular and Cellular Endocrinology.

[27]  E. Vicari,et al.  Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up. , 1992, International journal of andrology.

[28]  B. Zirkin,et al.  Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropin-releasing hormone. , 1992, Endocrinology.

[29]  R. Scully,et al.  Endocrine tumors of the ovary. , 1992, Current topics in pathology. Ergebnisse der Pathologie.

[30]  E. Nieschlag,et al.  Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). , 1991, Endocrinology.

[31]  W. Chin,et al.  Molecular biology of the pituitary gonadotropins. , 1990, Endocrine reviews.

[32]  R. Berger,et al.  Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21. , 1990, Cytogenetics and cell genetics.

[33]  H. Burger,et al.  Inhibin as a marker for granulosa-cell tumors. , 1989, The New England journal of medicine.

[34]  J. Concordet,et al.  Illegitimate transcription: transcription of any gene in any cell type. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Comino,et al.  Resistant ovary syndrome following oral contraception , 1987 .

[36]  R. Lewis,et al.  A single amino acid substitution in an ectopic alpha subunit of a human carcinoma choriogonadotropin. , 1986, The Journal of biological chemistry.

[37]  T. Khalil,et al.  Isolated follicle-stimulating hormone deficiency in men: successful long-term gonadotropin therapy. , 1984, Fertility and sterility.

[38]  R. Stouffer,et al.  Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers. , 1984, The Journal of clinical endocrinology and metabolism.

[39]  C. A. Paulsen,et al.  Clinical studies in an adult male patient with "isolated follicle stimulating hormone (FSH) deficiency". , 1983, Journal of andrology.

[40]  I. Huhtaniemi,et al.  Localization of luteinizing hormone, follicle-stimulating hormone, prolactin, and their receptors in human and rat testis using immunohistochemistry and radioreceptor assay. , 1983, The Journal of clinical endocrinology and metabolism.

[41]  D. Killinger,et al.  CLOMIPHENE IN TREATMENT OF MALE INFERTILITY DUE TO ISOLATED FOLLICLE-STIMULATING-HORMONE DEFICIENCY , 1979, The Lancet.

[42]  D. Rabinowitz,et al.  Isolated follicle-stimulating hormone deficiency revisited. Ovulation and conception in presence of circulating antibody to follicle-stimulating hormone. , 1979, The New England journal of medicine.

[43]  H. Wolny.  [Hormonal regulation of spermatogenesis]. , 1978, Wiadomosci lekarskie.

[44]  E. Hägg,et al.  Isolated FSH deficiency in a male. A case report. , 1978, Scandinavian journal of urology and nephrology.

[45]  A. Parlow,et al.  Isolated follicle-stimulating hormone deficiency in man. , 1977, Fertility and sterility.

[46]  W. Polishuk,et al.  Isolated deficiency of follicle-stimulating hormone. Clinical and laboratory features. , 1972, The New England journal of medicine.